Abstract
Post-epilepsy surgery antiepileptic drug discontinuation (AED) practices remain unclear and little evidence about the optimum timing exists. In the present study, we reviewed the types of surgery for epilepsy and their outcome. The current concepts for discontinuation of AED after surgery are presented and all contributing factors that should be taken into consideration are discussed.
Keywords: Epilepsy surgery, anti-epileptic drug, outcome, epilepsy, seizure, treatment.
Current Pharmaceutical Design
Title:AED Strategy after Refractory Epilepsy Surgery
Volume: 23 Issue: 42
Author(s): Andreas Zigouris, George A. Alexiou*, Marios S. Themistocleous and Spyridon Voulgaris
Affiliation:
- Department of Neurosurgery, University Hospital of Ioannina, Ioannina,Greece
Keywords: Epilepsy surgery, anti-epileptic drug, outcome, epilepsy, seizure, treatment.
Abstract: Post-epilepsy surgery antiepileptic drug discontinuation (AED) practices remain unclear and little evidence about the optimum timing exists. In the present study, we reviewed the types of surgery for epilepsy and their outcome. The current concepts for discontinuation of AED after surgery are presented and all contributing factors that should be taken into consideration are discussed.
Export Options
About this article
Cite this article as:
Zigouris Andreas, Alexiou A. George*, Themistocleous S. Marios and Voulgaris Spyridon, AED Strategy after Refractory Epilepsy Surgery, Current Pharmaceutical Design 2017; 23 (42) . https://dx.doi.org/10.2174/1381612823666171030154449
DOI https://dx.doi.org/10.2174/1381612823666171030154449 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuropsychiatric Systemic Lupus Erythematosus
Current Neuropharmacology Endocannabinoids and Their Receptors: Physiology, Pathology and Pharmacology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Neuropeptide Y as an Endogenous Antiepileptic, Neuroprotective and Pro-Neurogenic Peptide
Recent Patents on CNS Drug Discovery (Discontinued) An Integrated Drug Development Approach Applying Topological Descriptors
Current Computer-Aided Drug Design SkQ-1 Regulates Xanthine Oxidase Activity in the Settings of Epilepsic Seizures in Rats
Neuroscience and Biomedical Engineering (Discontinued) Nonsynaptic Receptors for GABA and Glutamate
Current Topics in Medicinal Chemistry Regulatory Triangle of Neurodegeneration, Adult Neurogenesis and MicroRNAs
CNS & Neurological Disorders - Drug Targets A Review of Agents Patented for their Neuroprotective Properties
Recent Patents on CNS Drug Discovery (Discontinued) New Advances in the Field of Calcium Channel Antagonists: Cardiovascular Effects and Structure-Activity Relationships
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Knowledge of Pharmacists about Anti-epileptic Drugs in a Developing Country
Current Drug Safety Synthesis and Evaluation of Anticonvulsant Activities of Pyrazol yl Semicarbazones. Part II
Letters in Drug Design & Discovery Therapeutic Potentials of Adenosine Receptors: The State of The Art
Current Pharmaceutical Design Local Cerebral Blood Flow is Preserved in Sepsis
Current Neurovascular Research GABA and Neuroactive Steroid Interactions in Glia: New Roles for Old Players?
Current Neuropharmacology Editorial
Current Pediatric Reviews Glycine Transporter Type-1 and its Inhibitors
Current Medicinal Chemistry Exosomes: Natural Carriers for siRNA Delivery
Current Pharmaceutical Design Targeting Kinin Receptors for the Treatment of Neurological Diseases
Current Pharmaceutical Design Dietary Interventions in Children with Autism Spectrum Disorders - An Updated Review of the Research Evidence
Current Clinical Pharmacology The Safety, Tolerability, Pharmacokinetics and Cognitive Effects of GSK239512, a Selective Histamine H<sub>3</sub> Receptor Antagonist in Patients with Mild to Moderate Alzheimer’s Disease: A Preliminary Investigation
Current Alzheimer Research